Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIO SZNOL

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1073501748
CMS profile
47970
Location
NEW HAVEN, CT

General Payments · PY2018–2024

$170,302.99

  • Reported across 145 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$22,418.39

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $11,400.00 2
Regeneron Pharmaceuticals, Inc. $8,220.89 7
PFIZER INC. $1,875.00 1
E.R. Squibb & Sons, L.L.C. $922.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24,519.45 38
PY2019 $19,900.34 44
PY2020 $15,492.25 8
PY2021 $30,489.25 14
PY2022 $38,533.56 19
PY2023 $18,949.75 11
PY2024 $22,418.39 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
E.R. Squibb & Sons, L.L.C. $922.50 02/01/2024 Consulting Fee Undisputed 01/23/2026 1101255195 CMS
PFIZER INC. $1,875.00 01/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1130939760 CMS
Regeneron Pharmaceuticals, Inc. $1,081.50 05/10/2024 Consulting Fee Undisputed 01/23/2026 1114405653 CMS
Regeneron Pharmaceuticals, Inc. $64.41 07/26/2024 Food and Beverage Undisputed 01/23/2026 1114405655 CMS
Regeneron Pharmaceuticals, Inc. $112.79 07/26/2024 Food and Beverage Undisputed 01/23/2026 1114405657 CMS
Regeneron Pharmaceuticals, Inc. $17.69 07/26/2024 Food and Beverage Undisputed 01/23/2026 1114405659 CMS
Regeneron Pharmaceuticals, Inc. $1,225.50 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114405661 CMS
Regeneron Pharmaceuticals, Inc. $4,085.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114405663 CMS
Regeneron Pharmaceuticals, Inc. $1,634.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114405665 CMS
Teva Pharmaceuticals USA, Inc. $5,700.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 1151612792 CMS
Teva Pharmaceuticals USA, Inc. $5,700.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 1151612816 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.